This roundup explores updated 2024-2025 COVID-19 vaccine effectiveness data, an FDA-cleared 4-pathogen home test, and new evidence on metformin for long COVID risk.
A large multinational cohort study evaluated whether COVID-19 vaccination during pregnancy reduces the risk of preeclampsia, a major hypertensive complication associated with SARS-CoV-2 infection.
Maternal COVID-19 vaccination was linked with fewer severe maternal outcomes; early mRNA vaccination showed no rise in malformations; in utero infection was tied to higher neurodevelopmental diagnoses.
...
Emerging data identify molecular subtypes of Long COVID, link pediatric disease to school absenteeism, and define occupational risk factors for persistent symptoms.
A new national analysis estimates the burden of COVID-19–associated illnesses, outpatient visits, hospitalizations, and deaths in the United States from October 2022 through September 2024, offering...
A cohort study published in JAMA Network Open evaluates whether establishing state medical operations coordination centers was associated with changes in interhospital transfer rates during occupancy stress...
Recent studies examine metformin for long COVID prevention, resistance exercise for post-COVID recovery, mRNA vaccines in cancer care, and vascular risks in children.
